Fundamental Analysis of Synaptogenix Inc - Growth / Value Index
SNPX - Valuation Highlights
Valuation Analysis
Price to Earning Ratio is 6.27 and EV to EBITDA is -114.73 suggesting company is undervalued.
Book Value in last 3 years is trending down
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 6.26 | -3.95 | -1793.30 % | |
| Price to Book | 1.91 | 0.087 | 130.77 % | 4.47 |
| Price to Sales | 5224.70 | 0 | 0 % | |
| Enterprise Value to EBITDA Multiple | -114.78 | 47.78 | 837.47 % |
SNPX - Profitability Highlights
Profitability Analysis
Earning Yield of 15.95 %
During the past twelve months, the company has given a strong Return On Equity of 32.26%
During the past twelve months, the company has given a strong Return On Asset of 26.07%
Tsr Profitability Index - Very Poor Score of 5.00
Piotroski F Score - Very Poor Value of 0.0
Very Low Dividend Yield of 0 %
In the last three years, the company has given poor Net Margin
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 32.26 | -2.30 | -113.22 % | -4.09 |
| Return On Asset | 26.07 | -1.80 | -112.22 % | -3.20 |
| Net Profit Margin | 83511.93 | 0 | 0 % | -9694.07 |
| Operating Profit Margin | -9091.56 | 0 | 0 % | -20755.40 |
| EBITDA Margin | 1993.30 | 0 | 0 % | -20743.62 |
Highlights
| Market Cap | 5155.32 K |
| Enterprise Value | -23506.18 K |
| Price/Book TTM | 1.91 |
| Outstanding Share | 1085.33 K |
| Float/ Outstanding Share | 110.72% |
| Dividend Yield | 0 % |
Share Holding
Guru Numbers
| Price/Graham No | 0.155 |
| Peter Lynch Ratio | 0 |
| Piotroski F Score | 0 |
| Altman Z Score | 0.0003 |
| Sloan Ratio | 0.203 |
| Peter Lynch Fair Value | 18.98 |
SNPX - Growth Highlights
Growth Analysis
Tsr Growth Index - Good Score of 67.50
Annual sales of the company is increased for three years in a row
Quarterly sales in last 5 years is trending up
Quarterly sales in last 5 Quarter is trending down
Annual sales in last 3 years is trending down
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 10274.00 | % | % |
| Gross Profit | -4657.00 | 11.08 % | % |
| EBITDA | 204792 | 109.92 % | 114.24 % |
| Net Profit | 8580.02 K | 109.85 % | 0 % |
| EPS | 0.759 | 105.91 % | NA |
SNPX - Stability Highlights
Stability Analysis
Tsr Stability Index - Excellent Score of 91.67
Company is Debt Free
Net Debt zero balance-sheet with high liquidity
Cash ratio of 6.70
Altman Z Score of 0.0015 suggest high risk
Company is unable to generate enough free cash to support the business.
Interest Coverage of 0
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0 | 0 % | 0 |
| Cash Ratio | 6.70 | -76.52 % | |
| Quick Ratio | 0 | 0 % | 7.14 |
| Shareholders Equity | 78.25 | -7.59 % | |
| Debt to EBITDA | 0 | 0 % |
Historical Valuation Ratios of Synaptogenix Inc
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Synaptogenix Inc
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Synaptogenix Inc
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Synaptogenix Inc
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)